The first Covid vaccine will arrive in Ireland later this year

Good news for the world that is waiting to find a solution against Covid. Leading pharmaceutical company says vaccine for Covid will be available worldwide next month, including in Ireland.

The drug is expected to arrive in Ireland before the end of this year. It is reported that the preparations for this have been completed.

The Pfizer Covid Wax, which has been submitted to Europe and the United States for recognition, will arrive in Ireland also.

Paul Reid, managing director of Pfizer Ireland, said that he is confident that the company’s Covid vaccine would be approved by the end of November and will deliver 100 million doses once approved.

Pfizer and its German partner, BioNTech, are currently in talks with the European Commission to reach an advance purchase agreement.

Ireland will be one of the first European countries to receive the vaccine once approved.

The two-dose vaccine is being tested on 44,000 people of all ages. Clinical trials of the vaccine are progressing rapidly. So far, the vaccine has been tested on 40,000 people and the second dose of the vaccine was tested on 35,000 people.

Reid says there are several steps that must be taken before the vaccine can be made available to the public.

The first step is to submit the vaccine to the US Food and Drug Administration (FDA) and the European Medicines Agency for early approval in early November.

The FDA will make its final decision on whether to approve the vaccine after consulting with its own scientists and independent scientists and evaluating public opinion.

At the same time, the company had informed the European Licensing Authority of the progress made at each stage since the start of the trials as part of gaining recognition of the urgency of the vaccine. Normally such information is transmitted only at the end of clinical trials.

Reid said the safety of the vaccine is of paramount importance to the company and the quality and stability of the vaccine must be ensured.

He also revealed that the test results of the vaccine are very promising.

The vaccine has been tested in people as young as 12 years of age as part of a study of its function in people of different ages.

Meanwhile, the European Commission has entered into pre-purchase agreements with three other companies which are, Oxford-AstraZeneca, Sanofi and Johnson & Johnson.

However, it is reported that Pfizer has now overtaken them and is now closer to its destination.

Once approved, the first batches of vaccine arrive in Ireland and the Immunization Advisory Group will decide who will be the first to be vaccinated.

The vaccine will initially be available to risk groups such as health workers and nursing home inmates who are at the forefront of the fight against Covid.

Reid, meanwhile, says that producing 1.3 billion doses for global use next year will be a challenge for the company.